You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

NSCLC Stage IV

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

NSCLC Stage IV Trial in New York (Pembrolizumab, Radiation, Chemotherapy)

Recruiting
  • NSCLC Stage IV
  • New York, New York
    NYU Langone Health
Jan 11, 2023

NSCLC Stage IV, ALK Fusion Protein Expression Trial (Peptide vaccine)

Not yet recruiting
  • NSCLC Stage IV
  • ALK Fusion Protein Expression
  • Peptide vaccine
  • (no location specified)
Jul 21, 2023

Clinical Implications for NSCLC Patients With Rare Mutations

Recruiting
  • NSCLC
  • +2 more
    • Shanghai, Shanghai, China
    • +1 more
    Jan 18, 2023

    High PD-L1 Expressing NSCLC Patients Treated With PD-1/PD-L1

    Suspended
    • NSCLC Stage IV
    • NSCLC, Stage IIIC
    • Primary Immune Response (PIR) test by Biodesix, Inc.
    • San Carlos, California
    • +1 more
    Jan 26, 2023

    NSCLC Stage IV Trial in Taipei (therapeutic thoracic surgery, Afatinib)

    Recruiting
    • NSCLC Stage IV
    • Taipei, Taiwan
    • +1 more
    Mar 8, 2022

    NSCLC, NSCLC Stage IV, NSCLC Stage IIIB Trial (MYTX-011)

    Not yet recruiting
    • NSCLC
    • +5 more
    • (no location specified)
    Dec 7, 2022

    NSCLC Stage IV, NSCLC Stage IIIB, NSCLC Stage IIIC Trial in China (Cadonilimab, Anlotinib, Docetaxel)

    Recruiting
    • NSCLC Stage IV
    • +2 more
    • Hefei, Anhui, China
    • +4 more
    Apr 15, 2023

    NSCLC Stage IIIB, NSCLC Stage IIIC, NSCLC Stage IV Trial in Worldwide (Dacomitinib)

    Active, not recruiting
    • NSCLC Stage IIIB
    • +4 more
    • Hong Kong, Hong Kong
    • +8 more
    Jan 10, 2023

    Using Ex Vivo Tumoroids To Predict Immunotherapy Response In

    Recruiting
    • Lung Cancer
    • +2 more
    • Standard of care immune checkpoint inhbitors
    • Fairway, Kansas
    • +1 more
    Sep 19, 2022

    Lung Cancer, NSCLC, Stage III, NSCLC Stage IV Trial in Drammen (sotorasib)

    Recruiting
    • Lung Cancer
    • +6 more
    • Drammen, Viken, Norway
      Vestre Viken Health Trust
    May 30, 2022

    Lung Cancer, NSCLC Stage IV, Metastatic NSCLC - NSCLC Trial in Kansas City, Overland Park, Lee's Summit (Cabozantinib,

    Not yet recruiting
    • Lung Cancer
    • +3 more
    • Kansas City, Kansas
    • +3 more
    May 12, 2023

    NSCLC Stage IV Trial in Hangzhou (SBRT)

    Recruiting
    • NSCLC Stage IV
    • SBRT
    • Hangzhou, Zhejiang, China
      Zhejiang Cancer Hospital
    May 22, 2022

    NSCLC Stage IV Trial (HLX26, Serplulimab, Pemetrexed)

    Not yet recruiting
    • NSCLC Stage IV
    • (no location specified)
    Mar 15, 2023

    NSCLC Stage IV Trial in Netherlands (18F-PD-L1)

    Recruiting
    • NSCLC Stage IV
    • 18F-PD-L1
    • Amersfoort, Netherlands
    • +7 more
    Nov 7, 2022

    NSCLC Stage IV, HIV, HBV Trial in Verona (Nivolumab and Ipilimumab)

    Not yet recruiting
    • NSCLC Stage IV
    • +4 more
    • Nivolumab and Ipilimumab
    • Verona, Veneto/Verona, Italy
      Centro Ricerche Cliniche
    Oct 26, 2022

    NSCLC Without Mutation in Epidermal Growth Factor Receptor (Disorder) Trial (tereotactic body radiotherapy)

    Not yet recruiting
    • Non-Small Cell Lung Cancer Without Mutation in Epidermal Growth Factor Receptor (Disorder)
    • tereotactic body radiotherapy
    • (no location specified)
    Dec 1, 2023

    NSCLC Stage IV, Checkpoint Inhibitor Trial in Shanghai (Nivolumab Combined with Anlotinib)

    Completed
    • NSCLC Stage IV
    • Checkpoint Inhibitor
    • Nivolumab Combined with Anlotinib
    • Shanghai, Shanghai, China
      Shanghai Chest hospital
    Jun 26, 2022

    Stage IIIB(N2) NSCLC, Stage IIA NSCLC, Stage IIB NSCLC Trial in Beijing (Pembrolizumab 200 mg IV infusion)

    Not yet recruiting
    • Stage IIIB(N2) Non-small Cell Lung Cancer
    • +3 more
    • Pembrolizumab 200 mg IV infusion
    • Beijing, Beijing, China
      Peking University
    May 30, 2023

    Oncology, NSCLC Stage IV, NSCLC, Stage III Trial in Drammen (UV1, Sagramostim, Anti-PD-1/PD-L1 treatment)

    Recruiting
    • Oncology
    • +2 more
    • UV1
    • +2 more
    • Drammen, Viken, Norway
      Vestre Viken Health Trust
    Aug 15, 2022

    Non Small Cell Lung Cancer Trial in Ostrava (Chemotherapy, Radiotherapy (RT) + Stereotactic Body Ratio Therapy (SBRT),

    Recruiting
    • Non Small Cell Lung Cancer
    • Chemotherapy
    • +2 more
    • Ostrava, Moravian-Silesian Region, Czechia
      University Hospital Ostrava
    Dec 19, 2022

    NSCLC Stage IV Trial in Bellinzona, Chur, Geneva (Atezolizumab)

    Recruiting
    • NSCLC Stage IV
    • Bellinzona, Switzerland
    • +2 more
    Apr 26, 2022

    Malignant Pleural Effusions, NSCLC Stage IV Trial in Hangzhou (M701 pleural infusion, Pleural drainage, Cisplatin pleural

    Not yet recruiting
    • Malignant Pleural Effusions
    • NSCLC Stage IV
    • M701 pleural infusion
    • +2 more
    • Hangzhou, Zhejiang, China
      Cancer Hospital of the University of Chinese Academy of Sciences
    Sep 14, 2022

    Aspirin in Combination With Trametinib and Dabrafenib

    Not yet recruiting
    • NSCLC
    • +4 more
    • Combind asprin with Trametinib and Dabrafenib
    • (no location specified)
    Aug 4, 2023

    NSCLC Stage IV, Oligometastasis Trial in Xi'an (Toripalimab in Combination With Platinum-based Chemotherapy, Surgical treatment

    Recruiting
    • NSCLC Stage IV
    • Oligometastasis
    • Toripalimab in Combination With Platinum-based Chemotherapy
    • +2 more
    • Xi'an, Shaanxi, China
      The Fourth Military Medical University Tangdu Hospital
    Sep 15, 2021

    NSCLC Stage IV Trial in Gauting (combination regimen tremelimumab /durvalumab, platinum-based chemo (SoC))

    Withdrawn
    • NSCLC Stage IV
    • combination regimen tremelimumab /durvalumab
    • platinum-based chemotherapy (SoC)
    • Gauting, Germany
      Asklepios Fachkliniken München-Gauting
    Sep 26, 2022